Your fact-checks will appear here
Available reporting and regulatory records in the provided sources show multiple consumer complaints and at least one formal product-safety report involving Gundry-branded supplements, and journalists...
has been the subject of at least one identifiable civil lawsuit alleging intellectual-property infringement and has appeared as a named physician in federal court filings; public reporting and regulat...
Available reporting shows Dr. Steven R. Gundry has been the subject of regulatory scrutiny over a 2021 conference abstract (American Heart Association expression of concern) and has faced at least one...
Available sources show litigation involving Steven R. Gundry, including a 2023 Bloomberg Law lawsuit accusing him of patent-related misconduct and numerous consumer complaints on BBB, but none of the ...
Government enforcement actions that resulted in fines, criminal charges, or regulatory penalties against Dr. Steven R. Gundry or his company are not documented in the provided reporting; the available...
A — and v. et al., naming among defendants—was filed in the on October 18, 2023 , and court-docket aggregators report the case as closed on December 27, 2024 ; however, the public sources provided do ...
Publicly available filings in the provided reporting show litigation tied to Gundry MD — notably a federal patent complaint naming Agoura Health Products LLC and US GundryMD LLC that is docketed in th...
Reporting shows at least one formal lawsuit touching Steven R. Gundry’s commercial activities — a patent infringement complaint by Epitracker Inc. and Seraphina Therapeutics alleging Gundry helped cre...